Eledon Pharmaceuticals Correlations
ELDN Stock | USD 3.92 0.07 1.82% |
The current 90-days correlation between Eledon Pharmaceuticals and Zura Bio Limited is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eledon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eledon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Eledon Pharmaceuticals Correlation With Market
Good diversification
The correlation between Eledon Pharmaceuticals and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Eledon |
Moving together with Eledon Stock
0.64 | EWTX | Edgewise Therapeutics | PairCorr |
0.7 | PRAX | Praxis Precision Med | PairCorr |
0.64 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.8 | AKRO | Akero Therapeutics | PairCorr |
0.88 | AMLX | Amylyx Pharmaceuticals | PairCorr |
0.72 | CRNX | Crinetics Pharmaceuticals | PairCorr |
Moving against Eledon Stock
0.82 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.81 | PALI | Palisade Bio | PairCorr |
0.74 | INZY | Inozyme Pharma | PairCorr |
0.68 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.68 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
0.66 | KTTA | Pasithea Therapeutics | PairCorr |
0.65 | KURA | Kura Oncology | PairCorr |
0.6 | TERN | Terns Pharmaceuticals | PairCorr |
0.55 | GOSS | Gossamer Bio | PairCorr |
0.49 | DYN | Dyne Therapeutics | PairCorr |
0.48 | XFOR | X4 Pharmaceuticals | PairCorr |
0.42 | BDRX | Biodexa Pharmaceticals Upward Rally | PairCorr |
0.88 | KO | Coca Cola Aggressive Push | PairCorr |
0.82 | TLK | Telkom Indonesia Tbk | PairCorr |
0.77 | PPERY | Bank Mandiri Persero | PairCorr |
0.6 | PPERF | Bank Mandiri Persero | PairCorr |
0.58 | BKRKF | PT Bank Rakyat | PairCorr |
0.44 | PBCRY | Bank Central Asia | PairCorr |
0.43 | CVS | CVS Health Corp Aggressive Push | PairCorr |
0.35 | PTAIY | Astra International Tbk | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Eledon Stock performing well and Eledon Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eledon Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
KPRX | 2.77 | (0.29) | 0.00 | (0.26) | 0.00 | 5.95 | 16.59 | |||
ZVSA | 4.67 | (0.99) | 0.00 | 0.60 | 0.00 | 9.17 | 78.93 | |||
SONN | 4.76 | (0.77) | 0.00 | 2.19 | 0.00 | 12.31 | 37.58 | |||
ZURA | 3.78 | (0.36) | 0.00 | (0.09) | 0.00 | 7.95 | 30.69 | |||
PHIO | 4.53 | (0.30) | 0.00 | (0.18) | 0.00 | 11.78 | 36.22 | |||
RNAZ | 7.63 | 1.05 | 0.10 | (0.44) | 6.52 | 22.00 | 68.80 | |||
QNRX | 6.21 | 0.47 | 0.07 | 0.37 | 6.73 | 17.65 | 74.46 |
Eledon Pharmaceuticals Corporate Management
Gregory Flesher | Consultant | Profile | |
Bryan JD | Corporate Counsel | Profile | |
John Herberger | Vice Operations | Profile | |
Paul Little | Chief Officer | Profile | |
David Hovland | Chief Officer | Profile | |
FACS FACS | Chief Officer | Profile |